2020
DOI: 10.3390/s20030888
|View full text |Cite
|
Sign up to set email alerts
|

An Oximetry Based Wireless Device for Sleep Apnea Detection

Abstract: Sleep related disorders can severely disturb the quality of sleep. Among these disorders, obstructive sleep apnea (OSA) is highly prevalent and commonly undiagnosed. Polysomnography is considered to be the gold standard exam for OSA diagnosis. Even though this multi-parametric test provides highly accurate results, it is time consuming, labor-intensive, and expensive. A non-invasive and easy to self-assemble home monitoring device was developed to address these issues. The device can perform the OSA diagnosis … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(13 citation statements)
references
References 30 publications
0
12
0
1
Order By: Relevance
“…Blood gas concentrations (oxygen saturation and end-tidal carbon dioxide monitoring) has been addressed in [ 15 , 80 , 125 , 126 , 127 ].…”
Section: Resultsmentioning
confidence: 99%
“…Blood gas concentrations (oxygen saturation and end-tidal carbon dioxide monitoring) has been addressed in [ 15 , 80 , 125 , 126 , 127 ].…”
Section: Resultsmentioning
confidence: 99%
“…To complete the proposed framework for OSA patient detection, apneic event detection from a minimal set of sensors is desired. This could be achieved by analyzing the SpO2 signal ( 28 , 29 ) or the cardiac and respiratory signals, which are already included in the current sensor set ( 30 , 31 ). Wearable trackers from several commercial companies already provide these signals, such as ( 32 ), ( 33 ), and ( 34 ).…”
Section: Discussionmentioning
confidence: 99%
“…One of the most promising due to its ease of use and low cost is the NOS, which mainly focuses on measuring the SpO2 signal, coupled with an ML- or DL-based classifier. Table 1 presents a summary of a number of these tools recently developed for symptomatic adults [ 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 ] and the pediatric population [ 28 , 29 , 30 , 31 , 32 , 33 , 34 ].…”
Section: Discussionmentioning
confidence: 99%